Tip:
Highlight text to annotate it
X
>> MY NAME IS HOLLY MILLER-TATE.
I'M A NURSE CLINICIAN AT NATIONWIDE CHILDREN'S
HOSPITAL AND OUR RESEARCH LOOKED AT INTER-STAGE WEIGHT
GAIN WITH HYPOPLASTIC LEFT HEART SYNDROME PATIENT
UNDERGOING THE HYBRID PROCEDURE.
THE HYBRID PROCEDURE IS AN ALTERNATIVE PALLIATION
FOR PATIENTS WITH HYPOPLASTIC LEFT HEART SYNDROME.
IT CONSISTS OF BILATERAL PULMONARY REBANDING,
STINTING OF THE DUCTUS ARTERIOSUS,
AND A BALLOON ATRIAL SEPTOSTOMY.
WE LOOKED AT THE INTER-STAGE PERIOD WHICH IS THE DISCHARGE
FROM THE HYBRID PROCEDURE TO THE ADMISSION
FOR THE COMPREHENSIVE STAGE II SURGERY AND WE LOOKED
AT THE WEIGHT GAIN IN THAT TIME FRAME.
WE COMPARED HOME MONITORED PATIENTS TO NON-HOME MONITORED
PATIENTS AND WHAT WE FOUND WERE THAT THE HOME
MONITORED PATIENTS GAINED WEIGHT BETTER THAN THE
NON-HOME MONITORED PATIENTS FOR THIS PATIENT,
OR THIS COMPLEX PATIENT POPULATION.